Viewing nowCombinationV-Forjial Tablets 5/160/10 Milligrams
Amlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.

MFDS item code 202106222 · Approved 2021.08.27 · Insurance code 694003590
Treatment of hypertension, improvement of dyslipidemia, and inhibition of atherosclerosis progression and cardiovascular disease risk
This medication is used for patients who require combination treatment with amlodipine/valsartan and rosuvastatin. The amlodipine/valsartan combination helps in cases where blood pressure control is difficult with monotherapy for essential hypertension. Rosuvastatin helps lower the risk of cardiovascular diseases by managing hypercholesterolemia and dyslipidemia. It is also used as an adjunct therapy in the dietary management of homozygous familial hypercholesterolemia and primary dysbetalipoproteinemia. It reduces the risks of stroke, myocardial infarction, and vascular reinterventions among patients at high risk of cardiovascular diseases. This medication improves cardiovascular health by simultaneously managing blood pressure and blood cholesterol.
Take 1 tablet of this medicine once daily with water. It is recommended that it be taken at the same time each day, if possible (e.g., before breakfast). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and rosuvastatin. Patients taking an amlodipine/valsartan combination and rosuvastatin as separate products may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience. 5/80 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 80 milligrams as monotherapy. 5/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or valsartan 160 milligrams as monotherapy. 10/160 milligrams: For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams or valsartan 160 milligrams as monotherapy, or with 5/160 milligrams. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). Do not administer the amlodipine/valsartan combination to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. In patients with moderate renal impairment, monitoring of potassium levels and creatinine is recommended. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan must not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with rosuvastatin and continue it throughout treatment. Rosuvastatin may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to a maintenance dose. Most patients are controlled with a maintenance dose of 10 milligrams once daily. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response, up to a maximum of 20 milligrams daily. Elderly patients: No dosage adjustment is required. Patients with renal impairment: No dosage adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering rosuvastatin 20mg to patients with moderate renal impairment. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer rosuvastatin to patients with active liver disease. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose of rosuvastatin is contraindicated in some of these patients.
This medication can cause serious harm to the fetus and newborn, especially during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. It should not be administered to pregnant or potentially pregnant women, or to breastfeeding women. Patients with severe liver or kidney impairment, as well as those with certain liver or kidney diseases, should avoid using this medication. Caution is necessary for patients with very low blood pressure or who have insufficient sodium and fluid in their bodies, as hypotension could occur. Patients with high potassium levels or those taking medications that can increase potassium should have their potassium levels monitored frequently. Patients with a history of heart failure, myocardial infarction, or angioedema, as well as those with severe aortic stenosis, should use this medication cautiously. Patients at high risk for muscle-related side effects, such as those with impaired kidney function, hypothyroidism, or a history of muscle disorders, should be monitored closely for symptoms of myalgia or myopathy while taking this medication. This medication may affect liver function; therefore, patients with a history of liver disease should have their liver function tests performed regularly. Dizziness and drowsiness may occur during driving or operating machinery; hence, caution is advised. There may be potential interactions with other medications while taking this medicine, especially when combined with certain antibiotics, antifungals, immunosuppressants, or fibrates, so consultation with a healthcare professional is necessary. Elderly individuals may be more sensitive to this medication, so it is advised to start with lower doses and monitor their condition closely. Any unusual symptoms, muscle pain, rashes, or severe fatigue that occur during treatment should be reported immediately to a healthcare professional.
Peripheral edema, heat sensation, increased ALT, increased AST, increased serum creatinine, flank pain, neck pain, dizziness, decreased sensation, nasopharyngitis, rash, nasopharyngitis, influenza, hypersensitivity, visual impairment, anxiety, headache, drowsiness, positional dizziness, sensory abnormalities, vertigo, tinnitus, tachycardia, palpitations, syncope, orthostatic hypotension, hypotension, cough, pharyngeal and laryngeal pain, diarrhea, nausea, abdominal pain, constipation, thirst, erythema, diaphoresis, rash, itching, joint swelling, back pain, arthritis, muscle cramps, lethargy, pollakiuria, polyuria, erectile dysfunction, edema, lymphedema, facial edema, fatigue, flushing, asthenia, facial flushing, chest pain, pain, nocturia, chest discomfort, abdominal discomfort, gastroesophageal reflux disease, neck pain, hypercholesterolemia, hypoglycemia, headache, itching, peripheral edema, hypotension, edema, chest pain, pain, cough, nocturia, chest pain, weight gain, arthralgia, skeletal pain, rhabdomyolysis, gingival hyperplasia, gastritis, nerve hyperexcitability, decreased sensation, Stevens-Johnson syndrome, pharyngitis, tonsillitis, spinal canal stenosis, aphasia, nausea, oral bleeding, vomiting, insulin-dependent diabetes mellitus, diabetic complications, leg fractures, spinal fractures, fractures, osteomyelitis, skin tumors, palpitations, second-degree atrioventricular block, vestibular neuritis, retinal detachment, unspecified benign skin tumor-like condition, herpes zoster, intervertebral disc herniation, laceration, diplopia, thrombocytopenia, leukopenia, allergic reaction, hyperglycemia, insomnia, emotional changes, tremors, taste disturbance, peripheral neuropathy, muscle hypertonicity, arrhythmia, bradycardia, atrial fibrillation, ventricular tachycardia, myocardial infarction, vasculitis, dyspnea, rhinitis, vomiting, dyspepsia, pancreatitis, gastritis, gingival hyperplasia, hepatitis, jaundice, alopecia, purpura, skin depigmentation, phototoxic reaction, vascular edema, urticaria, erythema multiforme, Stevens-Johnson syndrome, myalgia, urinary disturbance, nocturia, gynecomastia, pain, malaise, chest pain, weight loss, weight gain, serum sickness, increased serum potassium, vasculitis, elevated liver function tests, vascular edema, vesicular dermatitis, myalgia, renal failure, kidney damage, elevated serum creatinine, insomnia, decreased libido, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, interstitial lung disease, jaundice, hepatitis, increased transaminases, pruritus, rash, urticaria, myopathy, rhabdomyolysis, asthenia, multifocal neuropathy, amnesia, peripheral neuropathy, cough, dyspnea, thrombocytopenia, lupus-like syndrome, muscle rupture, immune-mediated necrotizing myopathy, hematuria, edema, headache, dizziness, increased ALT, chest pain, cough, myalgia, increased CK, constipation, increased AST, asthenia, joint pain, fatigue, numbness, sensory abnormalities, chest discomfort, nausea, abdominal pain, diarrhea, anorexia, abdominal distension, pruritus, abnormal liver function tests, syncope, generalized pain, muscle cramps, gout, erectile dysfunction
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent exposure to air or moisture. It is recommended to maintain a storage temperature between 1°C and 30°C at room temperature. Doing so can help preserve the effectiveness of the medication for an extended period.
Light orange oval film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
Daewoong Bio Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 80mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
CombinationAmlodipine Besylate 6.94mg · Valsartan 160mg +1 more
Tablet · Prescription medication · Combination
HK Inno.N Co., Ltd.
Valsartan 80mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharm Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 6.94mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Valsartan 160mg · Amlodipine Besylate 13.87mg +1 more
Tablet · Prescription medication · Combination
Kyungdong Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.